Koers Spherix Inc Nasdaq
Aandelen
US84842R3049
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
|
Omzet 2022 | - | Omzet 2023 | 2,04 mln. 1,9 mln. | Marktkapitalisatie | 15,37 mln. 14,35 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -22 mln. -20,54 mln. | Nettowinst (verlies) 2023 | -22 mln. -20,54 mln. | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 41,56 mln. 38,8 mln. | Nettoliquiditeiten 2023 | 12,93 mln. 12,07 mln. | EV/omzet 2023 | 1,2 x |
K/w-verhouding 2022 |
-0,67
x | K/w-verhouding 2023 |
-0,59
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 61,45% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Anthony Hayes
CEO | Chief Executive Officer | 56 | 01-03-13 |
Kyle Wool
PSD | President | - | 12-04-21 |
George M. Way
DFI | Director of Finance/CFO | - | 03-04-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Tim Ledwick
BRD | Director/Board Member | 66 | 09-07-15 |
Anthony Hayes
CEO | Chief Executive Officer | 56 | 01-03-13 |
Gregory Blattner
BRD | Director/Board Member | 47 | 03-05-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+38,65% | 39,36 mld. | |
-8,62% | 38,52 mld. | |
+26,95% | 30,74 mld. | |
+10,74% | 25,92 mld. | |
-13,50% | 26,03 mld. | |
+44,87% | 14,13 mld. | |
+34,36% | 12,73 mld. | |
-7,14% | 11,29 mld. | |
-12,61% | 10,64 mld. |
- Beurs
- Aandelen
- Koers DOMH
- Koers